Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction

Biomaterials

Volumn 61, Issue , 2015, Pages 339-348

  Gaetani, Roberto ^a,b,c   Feyen, Dries A M ^a   Verhage, Vera ^a   Slaats, Rolf ^a   Messina, Elisa ^b   Christman, Karen L ^c   Giacomello, Alessandro ^b   Doevendans, Pieter A F M ^a,d   Sluijter, Joost P G ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Cardiac progenitor cells; Cardiac regeneration; Cardiac tissue engineering; Heart failure; Tissue printing

Indexed keywords

CARDIOLOGY; CELL DEATH; CELL ENGINEERING; HEART; HYALURONIC ACID; TISSUE; TISSUE ENGINEERING;

CARDIAC PROGENITORS; CARDIAC REGENERATION; CARDIAC TISSUE ENGINEERING; HEART FAILURE; TISSUE PRINTING;

3D PRINTERS;

ACTININ; BETA INTEGRIN; COLLAGEN; GELATIN; HYALURONIC ACID; LAMIN A; LAMIN C; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL DIFFERENTIATION ASSAY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GEL; HEART FUNCTION; HEART INFARCTION; HEART PERFORMANCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARACRINE SIGNALING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; SURFACE PROPERTY; THICKNESS; ANIMAL; CARDIAC MUSCLE CELL; CELL CULTURE; CHEMISTRY; CYTOLOGY; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PERICARDIUM; PROCEDURES; SCID MOUSE; THREE DIMENSIONAL PRINTING; TISSUE SCAFFOLD; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELLS, CULTURED; FEMALE; GELATIN; HUMANS; HYALURONIC ACID; MICE; MICE, SCID; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PERICARDIUM; PRINTING, THREE-DIMENSIONAL; STEM CELL TRANSPLANTATION; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84939161281     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.05.005     Document Type: Article

References (40)

1. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
2. Garbern J.C., Lee R.T. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 2013, 12:689-698.
3. ISHLT: the International Society for Heart & Lung Transplantation (accessed 05.06.14.). http://www.ishlt.org/registries/slides.asp?slides=heartLungRegistry.
4. Dey D., Han L., Bauer M., Sanada F., Oikonomopoulos A., Hosoda T., Unno K., De Almeida P., Leri A., Wu J.C. Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ. Res. 2013, 112:1253-1262.
5. Bearzi C., Rota M., Hosoda T., Tillmanns J., Nascimbene A., De Angelis A., Yasuzawa-Amano S., Trofimova I., Siggins R.W., Lecapitaine N., Cascapera S., Beltrami A.P., D'Alessandro D.A., Zias E., Quaini F., Urbanek K., Michler R.E., Bolli R., Kajstura J., Leri A., Anversa P. Human cardiac stem cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14068-14073.
6. Goumans M.-J., de Boer T.P., Smits A.M., van Laake L.W., van Vliet P., Metz C.H.G., Korfage T.H., Kats K.P., Hochstenbach R., Pasterkamp G., Verhaar M.C., van der Heyden M.A.G., de Kleijn D., Mummery C.L., van Veen T.A.B., Sluijter J.P.G., Doevendans P.A. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res. 2007, 1:138-149.
7. Smits A.M., van Vliet P., Metz C.H., Korfage T., Sluijter J.P., Doevendans P.A., Goumans M.-J. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat. Protoc. 2009, 4:232-243.
8. Chimenti I., Smith R.R., Li T.-S., Gerstenblith G., Messina E., Giacomello A., Marbán E. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 2010, 106:971-980.
9. Vrijsen K.R., Sluijter J.P.G., Schuchardt M.W.L., van Balkom B.W.M., Noort W.A., Chamuleau S.A.J., Doevendans P.A.F.M. Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J. Cell Mol. Med. 2010, 14:1064-1070.
10. Bolli R., Chugh A.R., D'Amario D., Loughran J.H., Stoddard M.F., Ikram S., Beache G.M., Wagner S.G., Leri A., Hosoda T., Sanada F., Elmore J.B., Goichberg P., Cappetta D., Solankhi N.K., Fahsah I., Rokosh D.G., Slaughter M.S., Kajstura J., Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378:1847-1857.
11. Makkar R.R., Smith R.R., Cheng K., Malliaras K., Thomson L.E.J., Berman D., Czer L.S.C., Marbán L., Mendizabal A., Johnston P.V., Russell S.D., Schuleri K.H., Lardo A.C., Gerstenblith G., Marbán E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
12. Behfar A., Crespo-Diaz R., Terzic A., Gersh B.J. Cell therapy for cardiac repair-lessons from clinical trials. Nat. Rev. Cardiol. 2014, 11:232-246.
13. Terrovitis J., Lautamäki R., Bonios M., Fox J., Engles J.M., Yu J., Leppo M.K., Pomper M.G., Wahl R.L., Seidel J., Tsui B.M., Bengel F.M., Abraham M.R., Marbán E. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J. Am. Coll. Cardiol. 2009, 54:1619-1626.
14. Hou D., Youssef E.A.-S., Brinton T.J., Zhang P., Rogers P., Price E.T., Yeung A.C., Johnstone B.H., Yock P.G., March K.L. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005, 112:I150-I156.
15. Gaetani R., Rizzitelli G., Chimenti I., Barile L., Forte E., Ionta V., Angelini F., Sluijter J.P.G., Barbetta A., Messina E., Frati G. Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application. J. Cell. Mol. Med. 2010, 14:1071-1077.
16. Ye K.Y., Black L.D. Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction. J. Cardiovasc. Transl. Res. 2011, 4:575-591.
17. Gaetani R., Doevendans P.A., Metz C.H.G., Alblas J., Messina E., Giacomello A., Sluijter J.P.G. Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells. Biomaterials 2012, 33:1782-1790.
18. Sluijter, J. P. G.; Smeets, M. B.; Velema, E.; Pasterkamp, G.; de Kleijn, D. P. V Increase in collagen turnover but not in collagen fiber content is associated with flow-induced arterial remodeling. J. Vasc. Res. 41, 546-555.
19. Smits A.M., van Laake L.W., den Ouden K., Schreurs C., Szuhai K., van Echteld C.J., Mummery C.L., Doevendans P.A., Goumans M.-J. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res. 2009, 83:527-535.
20. Van Laake L.W., Passier R., Monshouwer-Kloots J., Nederhoff M.G., Ward-van Oostwaard D., Field L.J., van Echteld C.J., Doevendans P.A., Mummery C.L. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat. Protoc. 2007, 2:2551-2567.
21. Feyen D., Gaetani R., Liu J., Noort W., Martens A., den Ouden K., Doevendans P.A., Sluijter J.P.G. Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function. Cardiovasc. Res. 2013, 99:83-91.
22. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., Ganser A., Knapp W.H., Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198-2202.
23. Nunes S.S., Song H., Chiang C.K., Radisic M. Stem cell-based cardiac tissue engineering. J. Cardiovasc. Transl. Res. 2011, 4:592-602.
24. Segers V.F.M., Lee R.T. Biomaterials to enhance stem cell function in the heart. Circ. Res. 2011, 109:910-922.
25. Murphy W.L., McDevitt T.C., Engler A.J. Materials as stem cell regulators. Nat. Mater. 2014, 13:547-557.
26. Singelyn J.M., Sundaramurthy P., Johnson T.D., Schup-Magoffin P.J., Hu D.P., Faulk D.M., Wang J., Mayle K.M., Bartels K., Salvatore M., Kinsey A.M., Demaria A.N., Dib N., Christman K.L. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J. Am. Coll. Cardiol. 2012, 59:751-763.
27. Wall S.T., Yeh C.-C., Tu R.Y.K., Mann M.J., Healy K.E. Biomimetic matrices for myocardial stabilization and stem cell transplantation. J. Biomed. Mater. Res. A 2010, 95:1055-1066.
28. Tous E., Purcell B., Ifkovits J.L., Burdick J.A. Injectable acellular hydrogels for cardiac repair. J. Cardiovasc. Transl. Res. 2011, 4:528-542.
29. Radisic M., Christman K.L. Materials science and tissue engineering: repairing the heart. Mayo Clin. Proc. 2013, 88:884-898.
30. Chi N.-H., Yang M.-C., Chung T.-W., Chen J.-Y., Chou N.-K., Wang S.-S. Cardiac repair achieved by bone marrow mesenchymal stem cells/silk fibroin/hyaluronic acid patches in a rat of myocardial infarction model. Biomaterials 2012, 33:5541-5551.
31. Qian L., Shim W., Gu Y., Shirhan M., Lim K.P., Tan L.P., Lim C.H., Sin Y.K., Wong P. Hemodynamic contribution of stem cell scaffolding in acute injured myocardium. Tissue Eng. Part A 2012, 18:1652-1663.
32. Wang L., Ma W., Markovich R., Chen J.W., Wang P.H. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ. Res. 1998, 83:516-522.
33. Plotkin M., Vaibavi S.R., Rufaihah A.J., Nithya V., Wang J., Shachaf Y., Kofidis T., Seliktar D. The effect of matrix stiffness of injectable hydrogels on the preservation of cardiac function after a heart attack. Biomaterials 2014, 35:1429-1438.
34. Discher D.E., Janmey P., Wang Y.-L. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143.
35. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
36. Kurazumi H., Kubo M., Ohshima M., Yamamoto Y., Takemoto Y., Suzuki R., Ikenaga S., Mikamo A., Udo K., Hamano K., Li T.-S. The effects of mechanical stress on the growth, differentiation, and paracrine factor production of cardiac stem cells. PLoS One 2011, 6:e28890.
37. Pagliari S., Vilela-Silva A.C., Forte G., Pagliari F., Mandoli C., Vozzi G., Pietronave S., Prat M., Licoccia S., Ahluwalia A., Traversa E., Minieri M., Di Nardo P. Cooperation of biological and mechanical signals in cardiac progenitor cell differentiation. Adv. Mater. 2011, 23:514-518.
38. Serena E., Figallo E., Tandon N., Cannizzaro C., Gerecht S., Elvassore N., Vunjak-Novakovic G. Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp. Cell. Res. 2009, 315:3611-3619.
39. Bagó J.R., Soler-Botija C., Casaní L., Aguilar E., Alieva M., Rubio N., Bayes-Genis A., Blanco J. Bioluminescence imaging of cardiomyogenic and vascular differentiation of cardiac and subcutaneous adipose tissue-derived progenitor cells in fibrin patches in a myocardium infarct model. Int. J. Cardiol. 2013, 169:288-295.
40. Gnecchi M., He H., Noiseux N., Liang O.D., Zhang L., Morello F., Mu H., Melo L.G., Pratt R.E., Ingwall J.S., Dzau V.J. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006, 20:661-669.